AMX vs. VRTX
Compare and contrast key facts about América Móvil, S.A.B. de C.V. (AMX) and Vertex Pharmaceuticals Incorporated (VRTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMX or VRTX.
Correlation
The correlation between AMX and VRTX is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
AMX vs. VRTX - Performance Comparison
Key characteristics
AMX:
-0.32
VRTX:
0.30
AMX:
-0.28
VRTX:
0.55
AMX:
0.97
VRTX:
1.08
AMX:
-0.22
VRTX:
0.36
AMX:
-0.42
VRTX:
0.97
AMX:
20.40%
VRTX:
8.68%
AMX:
26.50%
VRTX:
28.26%
AMX:
-64.34%
VRTX:
-91.77%
AMX:
-21.31%
VRTX:
-15.85%
Fundamentals
AMX:
$52.64B
VRTX:
$128.84B
AMX:
$0.57
VRTX:
-$2.10
AMX:
0.27
VRTX:
1.37
AMX:
0.06
VRTX:
11.67
AMX:
2.30
VRTX:
7.85
AMX:
$897.96B
VRTX:
$11.09B
AMX:
$512.38B
VRTX:
$9.54B
AMX:
$308.56B
VRTX:
-$228.00M
Returns By Period
In the year-to-date period, AMX achieves a 19.99% return, which is significantly higher than VRTX's 7.98% return. Over the past 10 years, AMX has underperformed VRTX with an annualized return of 1.38%, while VRTX has yielded a comparatively higher 13.10% annualized return.
AMX
19.99%
23.88%
8.72%
-9.52%
9.45%
1.38%
VRTX
7.98%
-8.37%
-11.92%
5.99%
9.91%
13.10%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMX vs. VRTX — Risk-Adjusted Performance Rank
AMX
VRTX
AMX vs. VRTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for América Móvil, S.A.B. de C.V. (AMX) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMX vs. VRTX - Dividend Comparison
AMX's dividend yield for the trailing twelve months is around 2.95%, while VRTX has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMX América Móvil, S.A.B. de C.V. | 2.95% | 3.53% | 120.36% | 3.99% | 1.88% | 2.49% | 2.30% | 2.30% | 1.91% | 3.39% | 8.96% | 1.63% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
AMX vs. VRTX - Drawdown Comparison
The maximum AMX drawdown since its inception was -64.34%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for AMX and VRTX. For additional features, visit the drawdowns tool.
Volatility
AMX vs. VRTX - Volatility Comparison
The current volatility for América Móvil, S.A.B. de C.V. (AMX) is 9.47%, while Vertex Pharmaceuticals Incorporated (VRTX) has a volatility of 13.24%. This indicates that AMX experiences smaller price fluctuations and is considered to be less risky than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMX vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between América Móvil, S.A.B. de C.V. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMX vs. VRTX - Profitability Comparison
AMX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, América Móvil, S.A.B. de C.V. reported a gross profit of 144.52B and revenue of 232.04B. Therefore, the gross margin over that period was 62.3%.
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.41B and revenue of 2.77B. Therefore, the gross margin over that period was 86.9%.
AMX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, América Móvil, S.A.B. de C.V. reported an operating income of 44.81B and revenue of 232.04B, resulting in an operating margin of 19.3%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported an operating income of 630.10M and revenue of 2.77B, resulting in an operating margin of 22.8%.
AMX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, América Móvil, S.A.B. de C.V. reported a net income of 18.70B and revenue of 232.04B, resulting in a net margin of 8.1%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a net income of 646.30M and revenue of 2.77B, resulting in a net margin of 23.3%.